Quantcast

Latest ZaBeCor Pharmaceuticals Stories

2008-11-13 09:00:07

ZaBeCor Pharmaceuticals, a biotechnology company, has announced that the FDA has approved the company's investigational new drug application for the treatment of asthma. This approval enables the company to proceed with Phase I clinical trials in humans for its asthma drug candidate, Excellair. The investigational new drug (IND) review included ZaBeCor's clinical development plan, Phase I clinical trial protocols, manufacturing plans and extensive preclinical studies. According to the...

2008-09-25 09:00:16

US-based biotechnology company ZaBeCor Pharmaceuticals has announced the formation of its new subsidiary Biothorpe Pharmaceuticals, a biotechnology company focused on the development of siRNA, antisense and other molecular technologies for the treatment of cancer. Biothorpe's intellectual property portfolio includes the therapeutic use of siRNA and other oligonucleotides directed at Syk kinase. Biothorpe intends to license its intellectual property for the treatment of three cancers - acute...


Word of the Day
cruet
  • A vial or small glass bottle, especially one for holding vinegar, oil, etc.; a caster for liquids.
This word is Middle English in origin, and ultimately comes from the Old French, diminutive of 'crue,' flask.
Related